Edwards Lifesciences Corporation (EW)
NYSE: EW · IEX Real-Time Price · USD
89.54
+0.40 (0.45%)
May 20, 2024, 1:11 PM EDT - Market open
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for EW stock have an average target of 94.24, with a low estimate of 57 and a high estimate of 107. The average target predicts an increase of 5.25% from the current stock price of 89.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EW stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 5 |
| Buy | 7 | 7 | 8 | 8 | 8 | 7 |
| Hold | 8 | 9 | 6 | 6 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 18 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $86 → $103 | Hold → Strong Buy | Upgrades | $86 → $103 | +15.03% | May 14, 2024 |
| Barclays | Barclays | Buy Maintains $100 → $101 | Buy | Maintains | $100 → $101 | +12.80% | May 7, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $94 → $99 | Buy | Maintains | $94 → $99 | +10.57% | Apr 26, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $92 → $89 | Hold | Maintains | $92 → $89 | -0.60% | Apr 26, 2024 |
| Stifel | Stifel | Hold Maintains $83 → $85 | Hold | Maintains | $83 → $85 | -5.07% | Apr 26, 2024 |
Financial Forecast
Revenue This Year
6.72B
from 6.00B
Increased by 11.83%
Revenue Next Year
7.38B
from 6.72B
Increased by 9.84%
EPS This Year
2.84
from 2.30
Increased by 23.44%
EPS Next Year
3.19
from 2.84
Increased by 12.34%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.9B | 7.7B | 8.6B | 9.3B | 10.1B |
| Avg | 6.7B | 7.4B | 8.1B | 8.9B | 9.6B |
| Low | 6.3B | 6.8B | 7.3B | 8.2B | 8.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.5% | 15.3% | 16.5% | 15.7% | 13.8% |
| Avg | 11.8% | 9.8% | 9.2% | 10.4% | 8.3% |
| Low | 5.2% | 1.4% | -0.5% | 1.2% | -1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.94 | 3.40 | 3.93 | 4.19 | 4.80 |
| Avg | 2.84 | 3.19 | 3.54 | 3.98 | 4.38 |
| Low | 2.60 | 2.82 | 3.08 | 3.57 | 3.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 27.9% | 19.7% | 23.3% | 18.3% | 20.6% |
| Avg | 23.4% | 12.3% | 11.0% | 12.3% | 10.1% |
| Low | 12.9% | -0.6% | -3.5% | 0.7% | -2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.